Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-200-5 | CAS number: 92-88-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
Data in vitro and in vivo indicate that the substance is not a skin or eye irritant.
Key value for chemical safety assessment
Skin irritation / corrosion
Link to relevant study records
- Endpoint:
- skin irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 17 October 2011 to 5 December 2011
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Remarks:
- In vitro assay - EPISKIN - performed in accordance with Guideline OECD 439 with no remarkable deviations or deficiencies
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
- Deviations:
- no
- Principles of method if other than guideline:
- EPISKIN reconstructed human epidermis model
- GLP compliance:
- yes
- Test system:
- human skin model
- Remarks:
- cultured human epidermal keratinocytes
- Source species:
- other: Human
- Cell type:
- other: human derived epidermis keratinocytes
- Cell source:
- other: reconstructed human epidermis (RhE) model
- Details on test system:
- Test model
- Source: EPISKIN - reconstructed human epidermis - supplied by SkinEthic Laboratories, Nice, France
- Received at laboratory: 29 November 2011
- batch: 11-EKIN-044
- Functional controls: Quality controls: histology scoring, magnitute of viability and barrier function (IC50 determination).
Biological safety: absence of HIV1 and 2, Hepatitis B and C antigens, absence of bacteria, fungi and mycoplasma.
IN-LIFE DATES: Experimental start date: 18 October 2011; experimental completion date: 5 December 2011 - Type of coverage:
- other: 0.38 cm2 EPISKIN
- Preparation of test site:
- other: Test system examined on arrival - pale grey temperature indicator and orange pH indicator meaning te system was suitable for use. Culture dishes were incubated for 24 hours after arrival at 37C, at saturated humidity and 5% CO2.
- Vehicle:
- other: Various media used
- Controls:
- not required
- Amount / concentration applied:
- TEST MATERIAL
Negative control - D-PBS 20uL/well; three replicates
Positive control - 5% SDS in water 20uL/well; three replicates
Test material - 4,4-biphenol 20 mg/well; three replicates
Media:
SkinEthic Maintenance Medium: SkinEthic; batch: 11-MAIN3-060
SkinEthic Assay Medium : SkinEthic; batch: 11-ESSC-037 (Preliminary Phase) and 11-ESSC-048 (Main Assay)
Dulbecco’s Phosphate buffered saline (D-PBS): GIBCO; batch: 925780
Sterile water : Bieffe Medital; batch: 08K2901
MTT Reagent : Sigma; batch: MKBB1495
MTT Stock Solution : MTT Reagent 3 mg/ml in D-PBS
Stored at ambient conditions, protected from light; used on the day of dilution
MTT Ready-to-use Solution : MTT Stock Solution diluted 1:10 (v/v) with SkinEthic Assay Medium (final concentration 0.3 mg/ml of MTT)
Stored at ambient conditions, protected from light. Used within 1 hour from preparation
Acidic Isopropanol (0.04 N HCl in isopropanol): 12 N HCL (Analab; batch: 08B22050j) added to 2-propanol (Fluka; batch: 0001434790) - Duration of treatment / exposure:
- In the preliminary test, the non-specific reduction of MTT was evaluated. 2ml of MTT Ready-to-Use solution was incubated with 10 mg of the test material for 3 hours (saturated humidity, 5%CO2 at 37°C). The solution was examined after incubation for blue or purple appearance. The colouring potential interaction with the test system was tested by adding 10 mg of test material to 90 uL distilled water and vortex mixed for 15 minutes. The solution colour was evaluated at the end of the incubation time.
In the main assay, the test material and positive and negative controls were applied to live tissue, three replicates. The exposure period was 15 minutes; after exposure each tissue was rinsed with sterile D-PBS and transferred to a new well with 2 ml maintenance medium. The wells were incubated at saturated humidityand 5%CO2 at 37°C for the 42 hour recovery period. At the end of the recovery period samples of incubation medium were reserved (but not subjected to further analyses). The tissue inserts and controls were then incubated with 2 ml MTT ready to use solution for three hours at 37°C (saturated humidity, 5%CO2) .
Tissues were then removed, dried on absorbent paper and a total biopsy obtained using a biopsy punch. - Observation period:
- Not applicable
- Number of animals:
- Reconstructed human epidermal tissue. Three replicate live tissues per treatment
- Details on study design:
- In the main assay, the test material and positive and negative controls were applied to live tissue, three replicates. The exposure period was 15 minutes; after exposure each tissue was rinsed with sterile D-PBS and transferred to a new well with 2 ml maintenance medium. The wells were incubated at saturated humidity, 5%CO2 at 37°C for the 42 hour recovery period. At the end of the recovery period samples of incubation medium were reserved (but not subjected to further analyses). The tissue inserts and controls were then incubated with 2 ml MTT ready to use solution for three hours at saturated humidity, 5%CO2 at 37°C.
Tissues were then removed, dried on absorbent paper and a total biopsy obtained using a biopsy punch.
The epidermis was separated from the collagen matrix and both elements were placed into a microtube containing 500 uL of acidic isopropanol. The tubes were vortex mixed and preserved for three days at 4°C to allow for formazan extraction. After extraction and centrifugation to remove debris, 200 µL aliquots were read in duplicate for absorbance at 595 nm. OD values were recorded. Isopropanol samples were used as control blanks. - Irritation / corrosion parameter:
- % tissue viability
- Value:
- 119.4
- Remarks on result:
- no indication of irritation
- Remarks:
- Mean score from 3 replicates
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The potential of the test item 4,4-Biphenol to be irritant to skin was investigated in an in vitro skin irritation study using a commercial reconstructed human epidermis (RhE) model named EPISKIN. According to the histotoxic potential, when referred to the negative control, the test item is considered to have no effect on the test system (119.4% of mean cell viability when compared to negative control). The negative and positive controls gave the expected results and the study was accepted as valid.
According to the criteria defined in the guidelines for this test (cell viability less than 50%), the test item is not considered to have irritant effect on the skin under the reported experimental conditions. - Executive summary:
The potential for 4,4'-Biphenol to be irritant to the skin was investigated in an in vitro skin irritation study using a commercial reconstructed human epidermis (RhE) model - EPISKINTM. 4,4'-Biphenol as well as positive and negative controls, were tested for their ability to impair cell viability after an exposure period of 15 minutes followed by a 42 hour recovery period. The final endpoint of the assay is the colorimetric measurement of MTT reduction (blue formazan salt) in the test system as an index of cell viability. A preliminary test was carried out to assay the compatibility of the test item with the test system. In particular, the test item was assayed for the ability of reducing MTT and of colouring water per se. No interaction was recorded between the test item and MTT under the normal test condition. No colouring potential was recorded for the test item in contact with water. Therefore, no additional control was added to the main phase for the evaluation of non specific coloration which may have influenced evaluation of results. In the main assay, 4,4'-Biphenol was applied, as supplied, in three replicates at the treatment level of approximately 20 mg/epidermis unit (0.38 cm2 each). Positive and negative controls [a 5% (w/v) sodium dodecyl sulphate solution in water and Dulbecco’s phosphate buffered saline (D-PBS)] were concurrently tested, using the same number of replicates and test conditions, at a dose level of 20 μl/epidermis unit. The negative control gave the expected baseline value and variability, in agreement with the guideline indications. According to the method, the mean value is considered the baseline value of the experiment and thus represents 100% of cell viability. The positive control caused the expected cell death when compared to the negative control (10.1% of cell viability) even with a variability slightly higher than expected (CV% equal to 33.8 instead of less than 18), but the test was considered valid. 4,4'-Biphenol did not induce cell death, the mean viability was 119.4% with reference to the negative control. According to the established criteria (cell viability less than 50%), the test item is considered to have no irritant effect on the skin under the reported experimental conditions.
- Endpoint:
- skin irritation / corrosion
- Remarks:
- no data
- Type of information:
- experimental study
- Adequacy of study:
- disregarded due to major methodological deficiencies
- Study period:
- no details provided in publication issued in 1974
- Reliability:
- 3 (not reliable)
- Rationale for reliability incl. deficiencies:
- documentation insufficient for assessment
- Remarks:
- Insufficient details provided for either methods or results
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Test material applied uncovered to rabbit skin. No details of skin preparation or method of assessing reactions. A grade of response is quoted without any context for assessing the meaning of the individual grade.
- GLP compliance:
- no
- Species:
- rabbit
- Strain:
- not specified
- Details on test animals or test system and environmental conditions:
- no data
- Type of coverage:
- open
- Preparation of test site:
- not specified
- Vehicle:
- not specified
- Controls:
- not specified
- Amount / concentration applied:
- No details provided
- Duration of treatment / exposure:
- No details provided
- Observation period:
- no details provided
- Number of animals:
- No data
- Details on study design:
- No details are provided for the methods used in this range-finding screen. According to the tabulated results a rabbit or rabbits was/were exposed to the test material on the belly, without occlusion. Information relating to how or how long the material was retained in situ is not provided. A footnote indicates a suitable vehicle was used but does not give further details on the nature of the vehicle.
- Interpretation of results:
- study cannot be used for classification
- Remarks:
- Without a reference point the quoted value of "3" is meaningless
- Conclusions:
- A valid conclusion cannot be drawn given the sketchy details of the methods and isolated nature of the results score.
- Executive summary:
The study does not provide sufficient information on which to base a valid judgement of skin irritancy potential.
Referenceopen allclose all
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Eye irritation
Link to relevant study records
- Endpoint:
- eye irritation: in vivo
- Remarks:
- no data
- Type of information:
- experimental study
- Adequacy of study:
- disregarded due to major methodological deficiencies
- Study period:
- No details presented in the publication
- Reliability:
- 3 (not reliable)
- Rationale for reliability incl. deficiencies:
- other: Insufficient details provided for either methods or results.
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Corneal injury assessed following instillation into rabbit eye or eyes. No further details of method provided. The test material was dispersed in a vehicle prior to instillation. No details of the grading system are provided to indicate how the point value stated can be interpreted.
- GLP compliance:
- no
- Species:
- rabbit
- Strain:
- not specified
- Details on test animals or tissues and environmental conditions:
- No data
- Vehicle:
- not specified
- Controls:
- not specified
- Amount / concentration applied:
- No details provided
- Duration of treatment / exposure:
- No details provided
- Observation period (in vivo):
- No details provided
- Number of animals or in vitro replicates:
- No details provided
- Details on study design:
- No details provided. Corneal injury was assessed in one or more rabbits in a screening/range-finding assay.
- Irritation parameter:
- cornea opacity score
- Basis:
- animal: no data about the number of tested animals
- Time point:
- other: no data
- Score:
- 3
- Reversibility:
- not specified
- Remarks on result:
- other: A score of 3 is recorded but no grading system to indicate how this value relates to a degree of irritation
- Irritation parameter:
- iris score
- Basis:
- animal: no data
- Time point:
- other: no data
- Reversibility:
- not specified
- Remarks on result:
- not measured/tested
- Irritation parameter:
- conjunctivae score
- Basis:
- animal: no data
- Time point:
- other: no data
- Reversibility:
- not specified
- Remarks on result:
- not measured/tested
- Irritation parameter:
- chemosis score
- Basis:
- animal: no data
- Time point:
- other: no data
- Reversibility:
- not specified
- Remarks on result:
- not measured/tested
- Irritant / corrosive response data:
- Scored as 3. No indication given in the publication to aid interpretation of the value.
- Other effects:
- No details
- Interpretation of results:
- study cannot be used for classification
- Conclusions:
- A valid conclusion cannot be drawn given the sketchy details of the methods and isolated nature of the results score.
- Executive summary:
The study does not provide sufficient information on which to base a valid judgement of ocular irritancy potential.
- Endpoint:
- eye irritation: in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2 March 2012 to 26 May 2012
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Remarks:
- Study conducted to current guidelines and GLP without significant deviation
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 405 (Acute Eye Irritation / Corrosion)
- Deviations:
- no
- GLP compliance:
- yes
- Species:
- rabbit
- Strain:
- New Zealand White
- Details on test animals or tissues and environmental conditions:
- TEST ANIMALS
- Source:Harlan Italy s.r.l., San Pietro al Natisone, Italy
- Age at study initiation: 9-11 weeks old
- Weight at study initiation: 3.36 to 4.25 Kg
- Housing: Noryl cages with suspended perforated floors
- Diet (e.g. ad libitum): ad libitum Stanrab (P) SQC from Special Diet Services
- Water (e.g. ad libitum): ad libitum via cage bottles
- Acclimation period: at least 10 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19+/-2
- Humidity (%): 55+/-15
- Air changes (per hr):15-20
- Photoperiod (hrs dark / hrs light): 12 / 12
IN-LIFE DATES: From: 12 March 2012 To: 15 March 2012 - Vehicle:
- unchanged (no vehicle)
- Controls:
- not required
- Amount / concentration applied:
- TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 100 mg per eye
- Concentration (if solution): not applicable - Duration of treatment / exposure:
- Single application on Day 1. The eyes were not rinsed to remove the test material from the eye after a fixed period of time.
- Observation period (in vivo):
- Rabbits were observed for 72 hours after instillation.
- Number of animals or in vitro replicates:
- Three. The sentinel was dosed first followed by the remaining two rabbits
- Details on study design:
- REMOVAL OF TEST SUBSTANCE
- Washing (if done): Not done
SCORING SYSTEM: Draize system, according to test guideline - Irritation parameter:
- cornea opacity score
- Basis:
- mean
- Time point:
- 24/48/72 h
- Score:
- 0
- Max. score:
- 4
- Reversibility:
- other: no corneal reactions observed
- Irritation parameter:
- iris score
- Basis:
- mean
- Time point:
- 24/48/72 h
- Score:
- 0
- Max. score:
- 2
- Reversibility:
- other: No iridial changes recorded
- Irritation parameter:
- conjunctivae score
- Basis:
- mean
- Time point:
- 24/48/72 h
- Score:
- 0
- Max. score:
- 3
- Reversibility:
- fully reversible within: 24 hours
- Remarks on result:
- other: very slight erythema/conjnuctival redness recorded after one hour in one rabbit. Reactions had resolved by the 24 h assessment
- Irritation parameter:
- chemosis score
- Basis:
- mean
- Time point:
- 24/48/72 h
- Score:
- 0
- Max. score:
- 4
- Reversibility:
- other: no reeaction observed
- Irritant / corrosive response data:
- No significant ocular irritation was observed in any of the three treated rabbits. Mean scores for all parameters measured over the 24-72 h post instillation period were 0.0. No classification is required for ocular irritancy, No signal word or Hazard Statement required in accordance with Regulation 1272/2008
- Other effects:
- None
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The substance is not an eye irritant
- Executive summary:
Three rabbits were treated by instillation of 100 mg of undiluted 4,4-biphenol. The untreated eye acted as a concurrent control. Observations were recorded at 1, 24, 4 and 72 hours after instillation. Only one rabbit showed any changes with very slight conjunctival redness apparent at the first assessment point but resolved within 24 hours of dosing. No reactions were observed in the other two rabbits. The results of the in vivo test confirm the earlier in vitro assessment of severe irritation or corrosion, supporting the conclusion that no classification is required for 4,4 -biphenol and no signal word or Hazard statement is needed in accordance with the requirements of Regulation 1272/2008.
Referenceopen allclose all
No further information, no significant irritation effects observed in the study
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Respiratory irritation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
The potential of the test item 4,4-Biphenol to irritate skin was investigated in an in vitro skin irritation study using a commercial reconstructed human epidermis (RhE) model - EPISKIN. According to the histotoxic potential, when referred to the negative control, the test item is considered to have no effect on the test system (119.4% of mean cell viability when compared to negative control). The negative and positive controls gave the expected results and the study was accepted as valid. According to the criteria defined in the guidelines for this test (cell viability less than 50%), the test item is not considered to have irritant effect on the skin under the reported experimental conditions. Limited information on the lack of skin irritancy was obtained fom the absence of local irritation in a modern dermal toxicity study conducted in rats at the limit dose level.
An in vitro BCOP assay indicates the absence of corrosion or severe eye irritation; 4,4 -biphenol did not increase corneal opacity and no macroscopic evidence of opacity was recorded. Corneal permeability was also unaffected by treatment. Only minimal transient reactions were seen in a study of eye irritation in vivo. Older range-finding data are not considered to be sufficiently reliable in the absence of detailed methodology or results and only provide information relating to corneal effects.
Justification for selection of skin irritation / corrosion
endpoint:
The in vivo study requirement was waived on the basis of no
indication of skin irritation in the in vitro assay, confirmed by
limited data from an older range-finding study and the results of the
dermal toxicity investigation.
Justification for selection of eye irritation endpoint:
The in vivo results were negative for ocular irritation confirming
the in vitro results obtained for corneal changes
Justification for classification or non-classification
Results from in vitro screening assays for skin and eye irritation indicate no potential for eliciting irritant responses and consequently classification is not warranted for biphenyl-4,4'-diol.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.